000 | 01400 a2200457 4500 | ||
---|---|---|---|
005 | 20250517160732.0 | ||
264 | 0 | _c20171017 | |
008 | 201710s 0 0 eng d | ||
022 | _a1476-4687 | ||
024 | 7 |
_a10.1038/546S1a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSavage, Neil | |
245 | 0 | 0 |
_aPatience for patients. _h[electronic resource] |
260 |
_bNature _c06 2017 |
||
300 |
_aS1-S3 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAltruism |
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 | _aDrug Discovery |
650 | 0 | 4 | _aDrug Industry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xprevention & control |
650 | 0 | 4 | _aHope |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMalaria _xepidemiology |
650 | 0 | 4 |
_aMalaria Vaccines _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMotivation |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 | _aPatient Satisfaction |
650 | 0 | 4 |
_aPhthalazines _xtherapeutic use |
650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
650 | 0 | 4 |
_aResearch Personnel _xpsychology |
650 | 0 | 4 |
_aRotavirus Vaccines _ximmunology |
650 | 0 | 4 |
_aTenofovir _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVaccines, Attenuated _ximmunology |
650 | 0 | 4 | _aWomen's Health |
773 | 0 |
_tNature _gvol. 546 _gno. 7658 _gp. S1-S3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/546S1a _zAvailable from publisher's website |
999 |
_c27277212 _d27277212 |